News + Filings Holdings
All
13F
13D/G
Other
|
|
Soleus Capital Master Fund, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/16/2023 |
SC 13G
| Soleus Capital Master Fund, L.P. reports a 5.3% stake in Delcath Systems, Inc. |
| 08/11/2023 |
SC 13G
| Soleus Capital Master Fund, L.P. reports a 8.2% stake in Axogen, Inc. |
| 07/27/2023 |
SC 13G
| Soleus Capital Master Fund, L.P. reports a 5.1% stake in Verastem, Inc. |
| 04/14/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/22/2023 |
SC 13G
| Soleus Capital Master Fund, L.P. reports a 5.3% stake in RIGEL PHARMACEUTICALS INC. |
| 01/30/2023 |
SC 13G
| Soleus Capital Master Fund, L.P. reports a 5.7% stake in JASPER THERAPEUTICS, INC. |
| 01/27/2023 |
SC 13G
| Soleus Capital Master Fund, L.P. reports a 5.4% stake in PIERIS PHARMACEUTICALS, INC. |
| 10/13/2022 |
SC 13G
| Soleus Capital Master Fund, L.P. reports a 5.1% stake in Organogenesis Holdings Inc. |
| 09/02/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 09/02/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 09/01/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/18/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/27/2022 |
SC 13G
| Soleus Capital Master Fund, L.P. reports a 5.4% stake in PIERIS PHARMACEUTICALS, INC. |
| 12/20/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/23/2021 |
SC 13G
| Soleus Capital Master Fund, L.P. reports a 7.8% stake in THERATECHNOLOGIES, INC. |
|
|